Open Access
| Issue |
BIO Web Conf.
Volume 237, 2026
2026 8th International Conference on Biotechnology and Biomedicine (ICBB 2026)
|
|
|---|---|---|
| Article Number | 02025 | |
| Number of page(s) | 10 | |
| Section | Pharmacology, Natural Products and Drug Delivery | |
| DOI | https://doi.org/10.1051/bioconf/202623702025 | |
| Published online | 10 June 2026 | |
- Zhuang L, Sun Y, Cui X M, et al. Transmission of Severe Fever with Thrombocytopenia Syndrome Virus by Haemaphysalis longicornis Ticks, China[J]. Emerg Infect Dis, 2018, 24(5): 868–71. [Google Scholar]
- Tran X C, Yun Y, Van An L, et al. Endemic Severe Fever with Thrombocytopenia Syndrome, Vietnam[J]. Emerg Infect Dis, 2019, 25(5): 1029–1031. [Google Scholar]
- Li J, Wang C, Li X, et al. Direct transmission of severe fever with thrombocytopenia syndrome virus from farm-raised fur animals to workers in Weihai, China[J]. Virology Journal, 2024, 21(1): 113. [Google Scholar]
- Kim S C, Sekhon S S, Shin W R, et al. Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency[J]. Mol Cell Toxicol, 2022, 18(1): 1–8. [Google Scholar]
- Kim D, Lai C-J, Cha I, et al. Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development[J]. Viruses, 2024, 16(1): 128. [Google Scholar]
- Du S, Peng R, Xu W, et al. Cryo-EM structure of severe fever with thrombocytopenia syndrome virus[J]. Nature Communications, 2023, 14(1): 6333. [Google Scholar]
- Sun H, Hu Q, Lu S, et al. Current status of severe fever with thrombocytopenia syndrome in China (Review)[J]. Int J Mol Med, 2025, 56(5). [Google Scholar]
- Zong L, Yang F, Liu S, et al. CD8(+) T cells mediate antiviral response in severe fever with thrombocytopenia syndrome[J]. Faseb j, 2023, 37(1): e22722. [Google Scholar]
- Ji M, Hu J, Zhang D, et al. Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody[J]. EMBO Molecular Medicine, 2024, 16(3): 575–595. [Google Scholar]
- Zhang X, Zhang X, Lu J, et al. The mRNA vaccine encoding Gc protein confers complete protection against severe fever with thrombocytopaenia syndrome virus[J]. Vaccine, 2025, 63: 127631. [Google Scholar]
- Manzoni T B, Westover J B, Lundgreen K A, et al. Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein[J]. Viruses, 2025, 17(8): 1095. [Google Scholar]
- Riedl P, Wieland A, Lamberth K, et al. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential[J]. Journal of immunology (Baltimore, Md. : 1950), 2009, 183(1): 370–380. [Google Scholar]
- Shah M, Rafiq S, Woo H G. Challenges and considerations in multi-epitope vaccine design surrounding toll-like receptors[J]. Trends Pharmacol Sci, 2024, 45(12): 1104–1118. [Google Scholar]
- Dey J, Mahapatra S R, Singh P, et al. B and T cell epitope-based peptides predicted from clumping factor protein of Staphylococcus aureus as vaccine targets[J]. Microb Pathog, 2021, 160: 105171. [Google Scholar]
- Li G, Huang Z, Zhang C, et al. Construction of a linker library with widely controllable flexibility for fusion protein design[J]. Appl Microbiol Biotechnol, 2016, 100(1): 215–25. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.